Medindia

X

Biotest Pharmaceuticals Corporation Announces the Opening of its Newest Plasma Collection Facility in Kearney, Nebraska

Wednesday, November 30, 2016 Corporate News J E 4
Advertisement

BOCA RATON, Fla., Nov. 30, 2016 /PRNewswire/ -- Biotest Pharmaceuticals Corporation (BPC), a leading manufacturer of immunological biotherapeutic products, is pleased to announce the addition of its newest plasma collection center located at 5915 1st Avenue Kearney, Nebraska. The 15,200 square foot state-of-the-art facility officially opened its doors for business on November 29th, 2016 and brings the total number of BPC's plasma collection centers to twenty-two. 

Ileana Carlisle, BPC's Chief Executive Officer said "We are pleased to become a part of Kearney's growing community and look forward to being an active member here. This facility is just one more step forward in our resolve to better serve the thousands of patients worldwide whose lives are enhanced through plasma-based therapies."   

BPC has invested approximately $1.8 million in renovations of this newly constructed facility. The Company expects to add over 40 jobs to Kearney's local economy and currently has employment opportunities available for medical personnel and phlebotomists. 

In addition to supporting the local economy through employment opportunities, the Kearney Biotest Plasma Center is actively recruiting local residents to donate plasma. Plasma donors not only contribute the source material for these plasma-derived therapies which save the lives of thousands of patients but are also compensated for their donations.

About Biotest Pharmaceuticals Corporation

Biotest Pharmaceuticals is a wholly-owned subsidiary of Biotest AG, a German global provider of plasma products. The Company researches, develops and manufactures biotherapeutic plasma protein products, with a specialization in immunology and hematology and is a leader in the collection of source plasma. Biotest Pharmaceuticals owns and manages plasmapheresis centers across the United States and operates a state-of-the-art manufacturing facility in Boca Raton, Florida. We are committed to serving the thousands of patients worldwide who rely on plasma-based therapies.

Biotest Pharmaceuticals' team of over 1000 employees is part of Biotest AG's global workforce of more than 2,300 associates worldwide. To learn more about Biotest Pharmaceuticals, our Plasma Centers, and the difference we make in the lives of patients and the healthcare community, please visit us at www.biotestpharma.com and www.biotestplasma.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biotest-pharmaceuticals-corporation-announces-the-opening-of-its-newest-plasma-collection-facility-in-kearney-nebraska-300370555.html

SOURCE Biotest Pharmaceuticals Corporation

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Negative Pressure Wound Therapy Devices Market to ...
S
Immunodiagnostics Market to Reach $17,836 Million,...